Teva Pharmaceutical Industries (TEVA) R&D/CAPEX US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 848.7% | 172.5% | 172.1% | 152.9% | 181.2% | 185.4% | |||
Changes by years, y/y, % | +662pp | -676pp | 0pp | -19pp | +28pp | -0.6% |
Teva Pharmaceutical Industries. R&D/CAPEX, %
Teva Pharmaceutical Industries. R&D/CAPEX, changes, pp
Teva Pharmaceutical Industries (TEVA) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D/CAPEX, % | 201.7% | 169.8% | 189.2% | 190.8% | 195.2% | 185.4% | ||
Changes by years, y/y, % | +22pp | +26pp | +41pp | +43pp | +27pp | |||
Changes by quarters, q/q, % | +33pp | -32pp | +19pp | +2pp | +4pp |